Atlas FDA

NRP

5 FDA 510(k) clearances · Product code

125 daysmedian time to decision
212 days90th percentile
5clearances measured

FDA profile

Official device name
Sirolimus Test System
Device class
Class II (moderate risk)
Regulation
21 CFR 862.3840
Medical specialty
Clinical Toxicology
Flags
Third-party review eligible
FDA definition
Sirolimus test systems are intended for the quantitative measurement of sirolimus in whole blood as an aid in management of transplant patients taking this sirolimus.
Adverse events (MAUDE)
2006: 3 · 2010: 12
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
EMIT 2000 SIROLIMUS ASSAY, EMIT 2000 SIRO/TACRO SAMPLE PRETREATMENT REAGENT, AND EMIT 200 SIROLIMUS CALIBRATOR (K083487)Siemens Healthcare Diagnostics2009-03-30
DIMENSION SIRO FLEX REAGENT CARTRIDGE AND DIMENSION SIROLIMUS CALBIRATOR, MODELS DR 306, DC 306 (K081857)Siemens Healthcare Diagnostics, Inc.2008-10-30
ARCHITECT SIROLIMUS ASSAY (K070822)Fujirebio Diagnostics,Inc.2007-09-28
ABBOTT IMX SIROLIMUS MICROPARTICLE ENZYME IMMUNOASSAY (K042411)Axis-Shield , Ltd.2005-04-07
CEDIA SIROLIMUS ASSAY (DEN040008)Microgenics Corp.2004-07-28

Track NRP automatically

Every clearance here is in the API, with alerts when new ones post.